UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effect of Mild Physiologic Hyperglycemia on Insulin Secretion, Insulin Clearance, and Insulin Sensitivity in Healthy Glucose-Tolerant Subjects

Diabetes (New York, N.Y.), 2021-01, Vol.70 (1), p.204-213

2021

Volltextzugriff (PDF)

Effect of weight-maintaining ketogenic diet on glycemic control and insulin sensitivity in obese T2D subjects

BMJ open diabetes research & care, 2024-10, Vol.12 (5), p.e004199

2024

Volltextzugriff (PDF)

Dapagliflozin Enhances Fat Oxidation and Ketone Production in Patients With Type 2 Diabetes

Diabetes care, 2016-11, Vol.39 (11), p.2036-2041

2016

Volltextzugriff (PDF)

Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production

The Journal of clinical investigation, 2014-02, Vol.124 (2), p.509-514

2014

Volltextzugriff (PDF)

Mild Physiologic Hyperglycemia Induces Hepatic Insulin Resistance in Healthy Normal Glucose-Tolerant Participants

The journal of clinical endocrinology and metabolism, 2019-07, Vol.104 (7), p.2842-2850

2019

Volltextzugriff (PDF)

Chronic physiologic hyperglycemia impairs insulin-mediated suppression of plasma glucagon concentration in healthy humans

Metabolism, clinical and experimental, 2023-05, Vol.142, p.155512-155512, Article 155512

2023

Volltextzugriff (PDF)

Dapagliflozin Lowers Plasma Glucose Concentration and Improves β-Cell Function

The journal of clinical endocrinology and metabolism, 2015-05, Vol.100 (5), p.1927-1932

2015

Volltextzugriff (PDF)

853-P: Effect of Ketogenic Diet with Weight Maintenance in Type 2 Diabetes (T2D)

Diabetes (New York, N.Y.), 2023-06, Vol.72 (Supplement_1), p.1

2023

Volltextzugriff (PDF)

Effects of Sustained Hyperglycemia on Skeletal Muscle Lipids in Healthy Subjects

The journal of clinical endocrinology and metabolism, 2022-07, Vol.107 (8), p.e3177-e3185

2022

Volltextzugriff (PDF)

Pioglitazone Improves Left Ventricular Diastolic Function in Subjects With Diabetes

Diabetes care, 2017-11, Vol.40 (11), p.1530-1536

2017

Volltextzugriff (PDF)

Effect of Chronic Hyperglycemia on Glucose Metabolism in Subjects With Normal Glucose Tolerance

Diabetes (New York, N.Y.), 2018-12, Vol.67 (12), p.2507-2517

2018

Volltextzugriff (PDF)

1951-P: Prolonged (12-Hour) Glucagon Infusion Leads to Transient Elevation of Plasma Glucose but Sustained Elevation of Hepatic Glucose Production

Diabetes (New York, N.Y.), 2019-06, Vol.68 (Supplement_1)

2019

Volltextzugriff (PDF)

1967-P: Mild Physiologic Hyperglycemia Impairs Insulin-Mediated Suppression of Plasma Glucagon in Healthy Normal Glucose Tolerant Subjects

Diabetes (New York, N.Y.), 2019-06, Vol.68 (Supplement_1)

2019

Volltextzugriff (PDF)

Effect of Dapagliflozin With and Without Acipimox on Insulin Sensitivity and Insulin Secretion in T2DM Males

The journal of clinical endocrinology and metabolism, 2016-03, Vol.101 (3), p.1249-1256

2016

Volltextzugriff (PDF)

Chronic Reduction of Plasma Free Fatty Acid Improves Mitochondrial Function and Whole-Body Insulin Sensitivity in Obese and Type 2 Diabetic Individuals

Diabetes (New York, N.Y.), 2014-08, Vol.63 (8), p.2812-2820

2014

Volltextzugriff (PDF)

Mild Physiologic Hyperglycemia Impairs Beta-Cell Function and Induces Insulin Resistance in Healthy Normal Glucose Tolerant Subjects

Diabetes (New York, N.Y.), 2018-07, Vol.67 (Supplement_1)

2018

Volltextzugriff (PDF)

Mild Physiologic Hyperglycemia Induces Hepatic Insulin Resistance in Healthy Normal Glucose Tolerant Subjects–Role of Glucagon and Gluconeogenic Substrates

Diabetes (New York, N.Y.), 2018-07, Vol.67 (Supplement_1)

2018

Volltextzugriff (PDF)

Effects of Hyperglycemia on Skeletal Muscle Glucose Metabolism in Healthy Subjects

Diabetes (New York, N.Y.), 2018-07, Vol.67 (Supplement_1)

2018

Volltextzugriff (PDF)

644-P: Effect of PharmacologIC (EPIC) Therapy on Insulin Sensitivity and Beta-Cell Function in Prediabetes (PreDM)

Diabetes (New York, N.Y.), 2022-06, Vol.71 (Supplement_1)

2022

Volltextzugriff (PDF)

Pioglitazone reduces epicardial fat and improves diastolic function in patients with type 2 diabetes

Diabetes, obesity & metabolism, 2023-02, Vol.25 (2), p.426-434

2023

Volltextzugriff (PDF)

68-LB: Early Pharmacological Intervention (EPIC) to Preserve Beta-Cell Function in Prediabetes (PreDM)

Diabetes (New York, N.Y.), 2023-06, Vol.72 (Supplement_1), p.1

2023

Volltextzugriff (PDF)

274-OR: Beta-Cell Dysfunction Is Associated with Impaired Insulin-Mediated Suppression of Glucagon in Obese Hispanic Americans

Diabetes (New York, N.Y.), 2019-06, Vol.68 (Supplement_1)

2019

Volltextzugriff (PDF)

OR26-07 Mild Physiologic Hyperglycemia Does Not Affect Glucose Mediated but Impairs Insulin-Mediated Suppression of Plasma Glucagon in Healthy Normal Glucose Tolerant Subjects

Journal of the Endocrine Society, 2020-05, Vol.4 (Supplement_1)

2020

Volltextzugriff (PDF)

Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production

The Journal of clinical investigation, 2014-05, Vol.124 (5), p.2287-2287

2014

Volltextzugriff (PDF)

Mild Physiologic Hyperglycemia Induces Hepatic Insulin Resistance in Healthy Normal Glucose Tolerant Subjects

The journal of clinical endocrinology and metabolism, 2019-02

2019

Volltextzugriff (PDF)

1 – 25 von 25

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(25)

Sprache

Englisch
(25)

Erscheinungsjahr

n.n

Thema

Insulin
(15)
Life Sciences & Biomedicine
(14)
Science & Technology
(14)
Glucose
(13)
Insulin Resistance
(13)
Endocrinology & Metabolism
(12)
Humans
(11)
Diabetes
(10)
Diabetes Mellitus
(9)
Male
(8)
Middle Aged
(8)
Glucose Tolerance
(7)
Hyperglycemia
(7)
Adult
(6)
Beta Cells
(6)
Blood Glucose - Metabolism
(6)
Diabetes Mellitus, Type 2 - Drug Therapy
(6)
Female
(5)
Glucagon
(5)
Glucose Clamp Technique
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Effect of Mild Physiologic Hyperglycemia on Insulin Secretion, Insulin Clearance, and Insulin Sensitivity in Healthy Glucose-Tolerant Subjects

Effect of weight-maintaining ketogenic diet on glycemic control and insulin sensitivity in obese T2D subjects

Dapagliflozin Enhances Fat Oxidation and Ketone Production in Patients With Type 2 Diabetes

Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production

Mild Physiologic Hyperglycemia Induces Hepatic Insulin Resistance in Healthy Normal Glucose-Tolerant Participants

Chronic physiologic hyperglycemia impairs insulin-mediated suppression of plasma glucagon concentration in healthy humans

Dapagliflozin Lowers Plasma Glucose Concentration and Improves β-Cell Function

853-P: Effect of Ketogenic Diet with Weight Maintenance in Type 2 Diabetes (T2D)

Effects of Sustained Hyperglycemia on Skeletal Muscle Lipids in Healthy Subjects

Pioglitazone Improves Left Ventricular Diastolic Function in Subjects With Diabetes

Effect of Chronic Hyperglycemia on Glucose Metabolism in Subjects With Normal Glucose Tolerance

1951-P: Prolonged (12-Hour) Glucagon Infusion Leads to Transient Elevation of Plasma Glucose but Sustained Elevation of Hepatic Glucose Production

1967-P: Mild Physiologic Hyperglycemia Impairs Insulin-Mediated Suppression of Plasma Glucagon in Healthy Normal Glucose Tolerant Subjects

Effect of Dapagliflozin With and Without Acipimox on Insulin Sensitivity and Insulin Secretion in T2DM Males

Chronic Reduction of Plasma Free Fatty Acid Improves Mitochondrial Function and Whole-Body Insulin Sensitivity in Obese and Type 2 Diabetic Individuals

Mild Physiologic Hyperglycemia Impairs Beta-Cell Function and Induces Insulin Resistance in Healthy Normal Glucose Tolerant Subjects

Mild Physiologic Hyperglycemia Induces Hepatic Insulin Resistance in Healthy Normal Glucose Tolerant Subjects–Role of Glucagon and Gluconeogenic Substrates

Effects of Hyperglycemia on Skeletal Muscle Glucose Metabolism in Healthy Subjects

644-P: Effect of PharmacologIC (EPIC) Therapy on Insulin Sensitivity and Beta-Cell Function in Prediabetes (PreDM)

Pioglitazone reduces epicardial fat and improves diastolic function in patients with type 2 diabetes

68-LB: Early Pharmacological Intervention (EPIC) to Preserve Beta-Cell Function in Prediabetes (PreDM)

274-OR: Beta-Cell Dysfunction Is Associated with Impaired Insulin-Mediated Suppression of Glucagon in Obese Hispanic Americans

OR26-07 Mild Physiologic Hyperglycemia Does Not Affect Glucose Mediated but Impairs Insulin-Mediated Suppression of Plasma Glucagon in Healthy Normal Glucose Tolerant Subjects

Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production

Mild Physiologic Hyperglycemia Induces Hepatic Insulin Resistance in Healthy Normal Glucose Tolerant Subjects

Suchergebnisse filtern